Jerusalem Post: Fighting the Global Diabetes Epidemic with Israeli Innovation

Jerusalem-based Oramed Pharmaceuticals has developed an innovative oral insulin capsule transforming injectable treatments into oral therapies.

Oramed’s CEO Nadav Kidron speaks to The Jerusalem Post about the company’s technology .

 

You may also be interested

BioTuesdays: Oramed hopes to start Phase 3 oral insulin trial next year
Linkedin-in Facebook-f Twitter Youtube

Copyright © 2022 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy

Join our mailing list

Linkedin-in Facebook-f Twitter Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Annual shareholder meeting
Investor Relations
SEC filings
Investor FAQ
Governance documents
Investor tools
Oravax Medical
Skip to content